Latest Research in Extracellular vesicles in disease
13 research papers · 2026 median publication year
Top Research Topics in Extracellular vesicles in disease
- Extracellular vesicles in disease — 2 papers
- RNA Interference and Gene Delivery — 2 papers
- Sirtuins and Resveratrol in Medicine — 1 papers
- Chemical Synthesis and Analysis — 1 papers
- Ferroptosis and cancer prognosis — 1 papers
- Nanoplatforms for cancer theranostics — 1 papers
- Ion-surface interactions and analysis — 1 papers
- Nanoparticle-Based Drug Delivery — 1 papers
- Cancer Research and Treatments — 1 papers
- Neuroscience and Neural Engineering — 1 papers
Highest-Cited Papers
- Folate-Targeted polymeric micelles enhance the anti-glioma efficacy of pterostilbene in an orthotopic rat model
- Assessing persistent antitumor immunity induced by tumor derived extracellular vesicle hydrogel vaccination without neoantigen identification
- SuFEx Cyclization Enables DNA-Encoded Macrocyclic Peptide Libraries for Drug Discovery
- Effect of Side Chain Conjugation on the Cytotoxicity and siRNA Transfection Efficiency of 6-Amino-6-deoxy Curdlan
- Nanomedicines for resistant tumours in the central nervous system: novel materials and mechanisms of action
- Triple-Frequency Electromagnetic Stimulation Combined with Fingolimod Reduces Breast Cancer Cell Proliferation and Metastasis-Associated Extracellular Vesicle Protein Levels
- Paclitaxel-Loaded Phycocyanin Nanoformulation Attenuates EMT-Mediated Metastasis in Glioblastoma
- Strand-Resolved Mapping of siRNA Trafficking in Cells by Nanoscale Secondary Ion Mass Spectrometry
- Hybridoma-derived monoclonal antibody-conjugated carboplatin-loaded chitosan nanoparticles targeting A549 cells: an in vitro proof-of-concept study
- Advanced Materials for Biologics Delivery to Brain Tumors
- An EGFR-Targeted Fusogenic Tandem Peptide for siRNA Delivery in Glioblastoma
- First cell-patterning of primary, patient-derived mesenchymal glioblastoma brain cancer cells on parylene-C/SiO2 substrates
- A binding-to-release strategy for targeted anticancer drug delivery